Atomoxetine Once Daily for 24 Weeks in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Linda Wietecha(Eli Lilly (United States)), Keith E. Saylor, David Dunn(Indiana University – Purdue University Indianapolis), Robert L. Findling(Virginia Commonwealth University), Joel Young(Wayne State University), Dustin Ruff(Eli Lilly (United States))
Cited by 22
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Treatment Guidelines for Children and Adolescents With Bipolar Disorder
|Journal of the American Academy of Child & Adolescent Psychiatry|2005|455
Treatment Guidelines for Children and Adolescents With Bipolar Disorder
|Journal of the American Academy of Child & Adolescent Psychiatry|2006|353
Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
|American Journal of Psychiatry|2007|316